- Home
- IOVA vs CLM Comparison
IOVA vs CLM Comparison
Compare IOVA & CLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOVA
- CLM
- Stock Information
- Founded
- IOVA 2007
- CLM 1987
- Country
- IOVA United States
- CLM United States
- Employees
- IOVA N/A
- CLM N/A
- Industry
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- CLM Finance/Investors Services
- Sector
- IOVA Health Care
- CLM Finance
- Exchange
- IOVA Nasdaq
- CLM Nasdaq
- Market Cap
- IOVA 2.6B
- CLM 2.1B
- IPO Year
- IOVA N/A
- CLM N/A
- Fundamental
- Price
- IOVA $5.82
- CLM $8.86
- Analyst Decision
- IOVA Strong Buy
- CLM
- Analyst Count
- IOVA 9
- CLM 0
- Target Price
- IOVA $23.06
- CLM N/A
- AVG Volume (30 Days)
- IOVA 7.2M
- CLM 1.4M
- Earning Date
- IOVA 02-26-2025
- CLM 01-01-0001
- Dividend Yield
- IOVA N/A
- CLM 18.74%
- EPS Growth
- IOVA N/A
- CLM N/A
- EPS
- IOVA N/A
- CLM N/A
- Revenue
- IOVA $90,858,000.00
- CLM N/A
- Revenue This Year
- IOVA $13,803.28
- CLM N/A
- Revenue Next Year
- IOVA $167.55
- CLM N/A
- P/E Ratio
- IOVA N/A
- CLM N/A
- Revenue Growth
- IOVA 12751.20
- CLM N/A
- 52 Week Low
- IOVA $5.05
- CLM $6.25
- 52 Week High
- IOVA $18.33
- CLM $8.84
- Technical
- Relative Strength Index (RSI)
- IOVA 49.38
- CLM 53.96
- Support Level
- IOVA $5.44
- CLM $8.88
- Resistance Level
- IOVA $5.80
- CLM $8.96
- Average True Range (ATR)
- IOVA 0.31
- CLM 0.10
- MACD
- IOVA 0.09
- CLM -0.01
- Stochastic Oscillator
- IOVA 82.43
- CLM 70.69
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About CLM Cornerstone Strategic Value Fund Inc. New
Cornerstone Strategic Value Fund Inc is a closed-end management investment company. The fund's objective is to seek long-term capital appreciation through investments in equity securities of U.S. and non-U.S. companies. It invests in various sectors, which include financials, information technology, healthcare, consumer discretionary, industrials, utilities, energy, telecommunication services, materials, and other sectors.